Screener
Aurinia Pharmaceuticals AUPH Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Aurinia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Aurinia Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 8:16 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001600620-26-000062
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Inventory | 45,151 | 45,690 |
| Prepaid expenses and deposits | 10,531 | 5,746 |
| Other current assets | 1,381 | 1,080 |
| Total current assets | 541,324 | 491,967 |
| Deferred tax assets, net | 178,935 | 176,194 |
| Finance right-of-use lease assets | 65,152 | 73,865 |
| Intangible assets, net | 3,378 | 3,761 |
| Operating right-of-use lease assets | 1,518 | 3,596 |
Item 1. Financial Statements.
FAQ
- What is Aurinia Pharmaceuticals's total current assets?
- Aurinia Pharmaceuticals (AUPH) reported total current assets of $541.32M in Q2 2026.
- How has Aurinia Pharmaceuticals's total current assets changed year-over-year?
- Aurinia Pharmaceuticals's total current assets increased by 32.4% year-over-year, from $408.97M to $541.32M.
- What is the long-term trend for Aurinia Pharmaceuticals's total current assets?
- Over 5 years (2020 to 2025), Aurinia Pharmaceuticals's total current assets has grown at a 3.2% compound annual growth rate (CAGR), from $419.43M to $491.97M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Aurinia Pharmaceuticals's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude